Risk of COVID-19 for Patients with Cancer: A Narrative Overview

Mohamed Amine Baba; Youssef Bouchriti; Abderrahmane Achbani; Ahmed Kharbach; Hasnaa Sine; Aziz Naciri

doi:10.30935/ejmets/8257

EUROPEAN JOURNAL OF MEDICAL AND EDUCATIONAL TECHNOLOGIES

Risk of COVID-19 for Patients with Cancer: A Narrative Overview

Mohamed Amine Baba ¹ ² ^* , Youssef Bouchriti ¹ ³, Abderrahmane Achbani ¹ ⁴, Ahmed Kharbach ¹ ⁵, Hasnaa Sine ⁶, Aziz Naciri ⁷

More Detail

European Journal of Medical and Educational Technologies, Volume 13, Issue 3, Article No: em2008

https://doi.org/10.30935/ejmets/8257

OPEN ACCESS 660 Views 359 Downloads

Download Full Text (PDF)

Abstract

In March 2020, the WHO declared COVID-19 as a pandemic. At present, the curative vaccine has not yet been developed, older age and higher comorbidity levels are associated with more severe COVID-19 symptoms. Indeed, the cancer community currently faces many difficult questions.

Keywords: Coronavirus, COVID-19, cancer, 2019-nCoV, pneumonia, oncology

References

Sohrabi C, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 2020. (doi: 10.1016/j.ijsu.2020.02.034).
Yu J, et al. SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. medRxiv. 2020. (doi: 10.1101/2020.02.22.20025320).
Wu Z, McGoogan JM.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020; 323(13): 1239-42. (doi: 10.1001/jama.2020.2648).
Zhou P, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020; 579(7798): 270-3. (doi: 10.1038/s41586-020-2012-7).
Schreiber RD, Old LJ, Smyth M.J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science, 2011; 331(6024): 1565-70. (doi: 10.1126/science.1203486).
Zhu W, et al. The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease. Chinese Journal of Oncology, 2020; 42: E008-E008. (doi: 10.3760/cma.j.cn112152-20200303-00166).
Zhang L, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Annals of Oncology, 2020. (doi: 10.1016/j.annonc.2020.03.296).
Liang W, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology, 2020: 21(3): 335-7. (doi: 10.1016/S1470-2045(20)30096-6).
Yan X, et al. Clinical management of lung Cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19). Zhongguo Fei Ai Za Zhi, 2020; 23(3). (doi: 10.3779/j.issn.1009-3419.2020.03.02).
Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nature Reviews Clinical Oncology, 2020; 17(5): 268-70. (doi: 10.1038/s41571-020-0362-6).
Ueda M, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. Journal of the National Comprehensive Cancer Network, 2020; 1(aop): 1-4. (doi: 10.6004/jnccn.2020.7560).

Citation

Baba, M. A., Bouchriti, Y., Achbani, A., Kharbach, A., Sine, H., & Naciri, A. (2020). Risk of COVID-19 for Patients with Cancer: A Narrative Overview. European Journal of Medical and Educational Technologies, 13(3), em2008. https://doi.org/10.30935/ejmets/8257

Baba, M. A., Bouchriti, Y., Achbani, A., Kharbach, A., Sine, H., and Naciri, A. (2020). Risk of COVID-19 for Patients with Cancer: A Narrative Overview. European Journal of Medical and Educational Technologies, 13(3), em2008. https://doi.org/10.30935/ejmets/8257

Baba MA, Bouchriti Y, Achbani A, Kharbach A, Sine H, Naciri A. Risk of COVID-19 for Patients with Cancer: A Narrative Overview. European Journal of Medical and Educational Technologies. 2020;13(3), em2008. https://doi.org/10.30935/ejmets/8257

Baba, Mohamed Amine, Youssef Bouchriti, Abderrahmane Achbani, Ahmed Kharbach, Hasnaa Sine, and Aziz Naciri. "Risk of COVID-19 for Patients with Cancer: A Narrative Overview". European Journal of Medical and Educational Technologies 2020 13 no. 3 (2020): em2008. https://doi.org/10.30935/ejmets/8257

Baba, Mohamed Amine et al. "Risk of COVID-19 for Patients with Cancer: A Narrative Overview". European Journal of Medical and Educational Technologies, vol. 13, no. 3, 2020, em2008. https://doi.org/10.30935/ejmets/8257

Baba MA, Bouchriti Y, Achbani A, Kharbach A, Sine H, Naciri A. Risk of COVID-19 for Patients with Cancer: A Narrative Overview. European Journal of Medical and Educational Technologies. 2020;13(3):em2008. https://doi.org/10.30935/ejmets/8257